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EU-OPENSCREEN is a pan-European research infrastructure initiative that 
aims at enabling academic chemical biology research to develop novel small 
molecule research ‘tools’ for studies in all areas of the Life Sciences. The purpose of 
EU-OPENSCREEN is to provide researchers access to its shared resources, 
including the latest screening technologies, a unique compound collection composed 
of (up to 140 000) commercial and proprietary compounds, and medicinal chemistry 
support. Recently, we described a collaborative effort to define and apply a protocol 
for the rational selection of a general-purpose screening library, to be used by the 
screening platforms affiliated with the EU-OPENSCREEN initiative. Chemists are 
invited to include their compounds into this jointly-used collection and they receive 
back rich information about the biological activities from the screening against a wide 
range of bio-assays.  
EU-OPENSCREEN builds on national networks of chemists and biologists in 
16 European partner countries and takes advantage of their expertise and 
specialized facilities with many years of proven high quality services. This distributed 
network of partner sites embedded in their excellent research environments will serve 
as a truly pan-European infrastructure of open-access technology platforms with a 
broad, collaborative purpose. EU-OPENSCREEN covers the whole range of target 
families, biological topics or models. The chemical tools developed within EU-
OPENSCREEN will foster a wider use of the pharmacological approach in biology 
and help to enter new fields beyond the parent themes of pharmacology, human and 
veterinary medicine, and toxicology. By testing systematically the chemical collection 
of EU-OPENSCREEN in a multitude of highly standardized assays originating from 
very different biological themes, the screening process will generate valuable 
information on structure-activity relations of the substances and thereby enrich our 
understanding of how and where they act. Currently in its ‘transition phase’ EU-
OPENSCREEN will start full operations as a permanent ERIC (European Research 
Infrastructure Consortium) at the beginning of 2017. 
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